The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wahlstrom Mats since 2015.
This trader's CIK number is 1459154.
At the time of last reporting, Wahlstrom Mats was the Officer of Coherus Biosciences, Inc.. (stock ticker symbol CHRS).
Also see all insider trading activities at Coherus Biosciences, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | CHRS | 0 | $0 | 99,988 | $73,891 | 0 | $0 |
2024 | CHRS | 0 | $0 | 0 | $0 | 59,988 | $99,999 |
2020 | CHRS | 0 | $0 | 318,066 | $5,849,407 | 0 | $0 |
2016 | CHRS | 0 | $0 | 53,583 | $1,474,662 | 0 | $0 |
2015 | CHRS | 0 | $0 | 130,955 | $4,476,071 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | TLSI | 15,727 | $69,806 | 0 | $0 | 0 | $0 |
1. Coherus Biosciences, Inc. (CHRS)
2. Trisalus Life Sciences, Inc. (TLSI)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-23 | CHRS | Sale | 99,988 | .74 | 73,891 |
2024-02-01 | CHRS | Option Ex | 59,988 | 1.67 | 99,999 |
2020-06-17 | CHRS | Sale | 200,000 | 17.15 | 3,429,999 |
2020-03-03 | CHRS | Sale | 118,066 | 20.49 | 2,419,408 |
2016-12-07 | CHRS | Sale | 7,393 | 27.50 | 203,329 |
2016-12-08 | CHRS | Sale | 46,190 | 27.52 | 1,271,333 |
2015-08-18 | CHRS | Sale | 6,373 | 33.50 | 213,508 |
2015-08-17 | CHRS | Sale | 8,028 | 33.91 | 272,221 |
2015-08-14 | CHRS | Sale | 116,554 | 34.24 | 3,990,342 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-11-22 | TLSI | Buy | 5,000 | 4.55 | 22,750 |
2024-11-20 | TLSI | Buy | 2,040 | 4.16 | 8,486 |
2024-11-21 | TLSI | Buy | 8,687 | 4.44 | 38,570 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wahlstrom Mats (Officer of Coherus Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.